← Back to Search

Behavioral Intervention

Psychoeducational Intervention for Suicide Prevention in Abusive Relationships

N/A
Recruiting
Led By Nadine J. Kaslow, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Identifies as an African-American female
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 10, post-treatment months 6 and 12
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if teaching African-American women about their mental health and how to cope with abusive relationships can help reduce suicidal thoughts.

Who is the study for?
This trial is for African American women who have attempted suicide and experienced domestic violence within the last year. They must be seeking help at Grady Health System, with adequate mental status and literacy levels as measured by specific tests.
What is being tested?
The study compares usual treatment methods against special group sessions designed to empower these women, focusing on their cultural needs. The goal is to see if these empowerment sessions are more effective in helping them.
What are the potential side effects?
Since this trial involves psychoeducational interventions rather than medications, typical medical side effects are not expected. However, participants may experience emotional distress or discomfort during discussions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an African-American female.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 10, post-treatment months 6 and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 10, post-treatment months 6 and 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Beck Scale for Suicide Ideation Score
Change in Index of Spouse Abuse Score
Change in Suicide Attempt Index
Secondary study objectives
Change in Beck Depression Inventory- II
Change in Beck Hopelessness Scale
Change in Self-Efficacy Scale for Battered Women

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Psychoeducational intervention (PEI)Experimental Treatment1 Intervention
Culturally competent group empowerment psychoeducational treatment (group intervention that is culturally informed and educational in nature)
Group II: Enhanced Treatment as UsualActive Control1 Intervention
Enhanced treatment as usual that includes an adherence protocol (regular care at the hospital plus an adherence protocol)

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,775 Total Patients Enrolled
6 Trials studying Suicide Attempt
28,972 Patients Enrolled for Suicide Attempt
Emory UniversityLead Sponsor
1,700 Previous Clinical Trials
2,604,201 Total Patients Enrolled
Nadine J. Kaslow, PhDPrincipal InvestigatorEmory University

Media Library

Psychoeducational intervention (PEI) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT00601939 — N/A
Suicide Attempt Research Study Groups: Enhanced Treatment as Usual, Psychoeducational intervention (PEI)
Suicide Attempt Clinical Trial 2023: Psychoeducational intervention (PEI) Highlights & Side Effects. Trial Name: NCT00601939 — N/A
Psychoeducational intervention (PEI) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00601939 — N/A
~77 spots leftby Dec 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top